Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer
    1.
    发明申请
    Biomarkers of Response to Inhibition of Poly-ADP Ribose Polymerase (PARP) in Cancer 审中-公开
    生物标志物对癌症中多聚ADP核糖聚合酶(PARP)的抑制作用

    公开(公告)号:US20160138114A1

    公开(公告)日:2016-05-19

    申请号:US14899974

    申请日:2014-06-18

    摘要: Provided herein are methods of identifying a subject having a poly-ADP ribose polymerase (PARP) inhibitor-sensitive tumor by detecting a genomic gain in chromosome 1q21 and/or chromosome 20q13.3 in a tumor sample from the subject. Also provided are methods of identifying a subject having a PARP inhibitor-sensitive tumor by detecting gene amplification of a CHD1L gene or an RTEL1 gene in a tumor sample from the subject. Further provided are methods of treating a tumor with a genomic gain in chromosome 1q21 and/or chromosome 20q13.3 in a subject by administering an effective dose of a PARP inhibitor.

    摘要翻译: 本文提供了通过检测来自受试者的肿瘤样品中的染色体1q21和/或染色体20q13.3中的基因组增益来鉴定具有多聚ADP核糖聚合酶(PARP)抑制剂敏感性肿瘤的受试者的方法。 还提供了通过检测来自受试者的肿瘤样品中CHD1L基因或RTEL1基因的基因扩增来鉴定具有PARP抑制剂敏感性肿瘤的受试者的方法。 还提供了通过施用有效剂量的PARP抑制剂来治疗受试者中染色体1q21和/或染色体20q13.3中的基因组增益的肿瘤的方法。